Literature DB >> 18353443

Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controls.

Koyi Choi1, Hean Zhuang, Barbara Crain, Sylvain Doré.   

Abstract

Neuroinflammation, a major contributor to neurodegenerative diseases, involves the contribution of activated microglia, reactive astrocytes, and infiltrating inflammatory cells. Stress and various acute or chronic brain injuries stimulate the generation of free radicals and glutamate, triggering inflammatory pathways that lead to increases in chemokines, cytokines, and prostaglandins. Prostaglandins are lipid mediators of inflammation that are produced from arachidonic acid by cyclooxygenase enzymes. They are generally believed to be in all tissues and organs. Their transport through the lipid bilayers of the cell membranes/organelles is facilitated by the prostaglandin transporter (PGT). In this study, middle frontal gyrus brain tissue from patients diagnosed with Alzheimer disease (AD) and that of age-matched control brains were examined to determine the protein expression pattern of PGT and its possible role in modulating neuroinflammation associated with AD. Immunohistochemical and immunofluorescent studies showed that PGT protein was expressed in all the brain tissues examined and was localized in neurons, microglia, and astrocytes. Interestingly, Western blot analysis revealed that the PGT level was significantly less in AD than in age-matched control brain homogenates. Further work is warranted to address the possibility and implications that prostaglandins might not be cleared at a proper rate in AD brains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353443      PMCID: PMC2365511          DOI: 10.1016/j.jneuroim.2008.01.014

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  42 in total

1.  Prostaglandin transporter PGT is expressed in cell types that synthesize and release prostanoids.

Authors:  Yi Bao; Michael L Pucci; Brenda S Chan; Run Lu; Shigekazu Ito; Victor L Schuster
Journal:  Am J Physiol Renal Physiol       Date:  2002-06

Review 2.  Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.

Authors:  G Halliday; S R Robinson; C Shepherd; J Kril
Journal:  Clin Exp Pharmacol Physiol       Date:  2000 Jan-Feb       Impact factor: 2.557

3.  Comparison between isopropyl unoprostone and latanoprost by prostaglandin E(2)induction, affinity to prostaglandin transporter, and intraocular metabolism.

Authors:  Kenji Kashiwagi; Naoaki Kanai; Takayuki Tsuchida; Michihiro Suzuki; Yoko Iizuka; Yuko Tanaka; Shigeo Tsukahara
Journal:  Exp Eye Res       Date:  2002-01       Impact factor: 3.467

Review 4.  Neuroinflammation, COX-2, and ALS--a dual role?

Authors:  Christopher Consilvio; Andrea M Vincent; Eva L Feldman
Journal:  Exp Neurol       Date:  2004-05       Impact factor: 5.330

5.  The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs.

Authors:  Glen Reid; Peter Wielinga; Noam Zelcer; Ingrid van der Heijden; Annemieke Kuil; Marcel de Haas; Jan Wijnholds; Piet Borst
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-30       Impact factor: 11.205

6.  Prostaglandin biosynthesis, transport, and signaling in corpus luteum: a basis for autoregulation of luteal function.

Authors:  J A Arosh; S K Banu; P Chapdelaine; E Madore; J Sirois; M A Fortier
Journal:  Endocrinology       Date:  2004-01-21       Impact factor: 4.736

7.  Augmented heme oxygenase-1 induces prostaglandin uptake via the prostaglandin transporter in micro-vascular endothelial cells.

Authors:  Michael L Pucci; Bindu Chakkalakkal; Elvira L Liclican; Alexander J Leedom; Victor L Schuster; Nader G Abraham
Journal:  Biochem Biophys Res Commun       Date:  2004-10-29       Impact factor: 3.575

Review 8.  Inflammatory processes in Alzheimer's disease.

Authors:  Edith G McGeer; Patrick L McGeer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-08       Impact factor: 5.067

9.  Prostaglandin transporter expression in mouse brain during development and in response to hypoxia.

Authors:  S Scafidi; R M Douglas; R Farahani; K J Banasiak; G G Haddad
Journal:  Neuroscience       Date:  2007-04-11       Impact factor: 3.590

10.  Molecular cloning and spatio-temporal expression of the prostaglandin transporter: a basis for the action of prostaglandins in the bovine reproductive system.

Authors:  Sakhila K Banu; Joe A Arosh; Pierre Chapdelaine; Michel A Fortier
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-16       Impact factor: 11.205

View more
  13 in total

Review 1.  Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins.

Authors:  Takeo Nakanishi; Ikumi Tamai
Journal:  AAPS J       Date:  2017-12-04       Impact factor: 4.009

Review 2.  The expression and function of organic anion transporting polypeptides in normal tissues and in cancer.

Authors:  Amanda Obaidat; Megan Roth; Bruno Hagenbuch
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-08-15       Impact factor: 13.820

3.  Effect of Insulin Receptor-Knockdown on the Expression Levels of Blood-Brain Barrier Functional Proteins in Human Brain Microvascular Endothelial Cells.

Authors:  Hinako Nagano; Shingo Ito; Takeshi Masuda; Sumio Ohtsuki
Journal:  Pharm Res       Date:  2021-11-22       Impact factor: 4.200

Review 4.  Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂.

Authors:  Jessica K Norberg; Earlphia Sells; Hui-Hua Chang; Srinivas R Alla; Shuxing Zhang; Emmanuelle J Meuillet
Journal:  Pharm Pat Anal       Date:  2013-03

Review 5.  The SLCO (former SLC21) superfamily of transporters.

Authors:  Bruno Hagenbuch; Bruno Stieger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

6.  Prostaglandin Transporter OATP2A1/SLCO2A1 Is Essential for Body Temperature Regulation during Fever.

Authors:  Yoshinobu Nakamura; Takeo Nakanishi; Hiroaki Shimada; Junya Shimizu; Rika Aotani; Shio Maruyama; Kei Higuchi; Takashi Okura; Yoshiharu Deguchi; Ikumi Tamai
Journal:  J Neurosci       Date:  2018-05-21       Impact factor: 6.167

7.  Quantification of Prostaglandin E2 Concentration in Interstitial Fluid from the Hypothalamic Region of Free-moving Mice.

Authors:  Yoshinobu Nakamura; Takatoshi Sakaguchi; Ikumi Tamai; Takeo Nakanishi
Journal:  Bio Protoc       Date:  2019-08-05

8.  Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy.

Authors:  Veronika Buxhofer-Ausch; Lena Secky; Katrin Wlcek; Martin Svoboda; Valentinos Kounnis; Evangelos Briasoulis; Andreas G Tzakos; Walter Jaeger; Theresia Thalhammer
Journal:  J Drug Deliv       Date:  2013-02-03

Review 9.  Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.

Authors:  Maria E Figueiredo-Pereira; Patricia Rockwell; Thomas Schmidt-Glenewinkel; Peter Serrano
Journal:  Front Mol Neurosci       Date:  2015-01-13       Impact factor: 5.639

10.  Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain.

Authors:  J S Rao; S I Rapoport; H-W Kim
Journal:  Transl Psychiatry       Date:  2011-08-16       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.